Sanofi to buy US blood disorder drugmaker for up to $9.5bn

French company’s purchase of Blueprint Medicines boosts immunology pipeline

Jun 2, 2025 - 09:40
 0
Sanofi to buy US blood disorder drugmaker for up to $9.5bn
French company’s purchase of Blueprint Medicines boosts immunology pipeline